<p>The present invention relates to compounds of Formula (I) and their pharmaceutically acceptable salts, wherein the substituents are as described herein, and their use in medicine, in particular as Trk antagonists.</p>
申请公布号
CA2885259(A1)
申请公布日期
2014.04.10
申请号
CA20132885259
申请日期
2013.09.26
申请人
PFIZER LIMITED
发明人
ANDREWS, MARK DAVID;BAGAL, SHARANJEET KAUR;BROWN, DAVID GRAHAM;GIBSON, KARL RICHARD;KLUTE, WOLFGANG;MORAO, INAKI;OMOTO, KIYOYUKI;RYCKMANS, THOMAS;SABNIS, YOGESH;SKERRATT, SARAH ELIZABETH;STUPPLE, PAUL ANTHONY